Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fundación PETHEMA is a leading Spanish cooperative group and scientific foundation dedicated to clinical and biological research in hematological malignancies. It coordinates a vast network of hospitals to conduct multicenter clinical trials, establishing standardized treatment protocols that have become international benchmarks, particularly in Acute Promyelocytic Leukemia (APL). The foundation focuses on optimizing therapeutic strategies for leukemia, lymphoma, and multiple myeloma through the integration of molecular diagnostics and innovative drug therapies. PETHEMA collaborates extensively with the pharmaceutical industry and international research networks like European LeukemiaNet to improve patient outcomes and advance the field of hematology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fundación PETHEMA.